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Quntifttiw caner risk t isadynic field, moredosely coed to rapidly advancing biomec resah
taneverbo Sxasofcangeandgrowthare nifid: an mmodelsofcancer toamore conm-
pidepictur ofthe tota c ec proce rnd fr curve- bto l ly bmdmodek;moement mupper-
boundestimatestobest tima, withamorecomp-ete treatmentofunerti; ncreased oftheroleof
sceptibility; growing dvlopmet ofexpert systems and decision support sstem; and e ingimportance ofrisk
communication.
Becausequantitativecancerriskassessmenthasbeenwoven
intothefabricofgovernmentregulatoryprocesses, onemightex-
pect to find its methods carved into bureaucratic stone. The
papersoncancerriskmodelingatthissymposiumattestthatthis
isnotthecase; indeed, quantitativecancer riskassessmentre-
mains a dynamic area of research. Risk analysts with varied
academic backgrounds continuetoimproveorreplace models
thatsometimes stembacktothe 1950s. Riskassessmentispro-
bablymorecloselycouplednowtorapidlyadvancingbiomedical
research than ithas everbeenbefore.
First, earlycancerriskassessmentmodelsfocusedalmosten-
tirely on models ofcancer initiation, e.g., the one-hit model.
Thereisagrowingtrendtoexpandassessmentmodelstoamore
complete picture of the total process, including exposure,
metabolic activation, pharnacokinetics, biologically effective
dose, initiation, cellular proliferation, promotion, immuno-
control, suppression, andprogression. Insomecases, modelsof
individual processes are linkedtogether forassessment, while
inothers several processes are incorporated ina singlemodel.
Thislargely reflects betterunderstanding ofcarcinogenic pro-
cessesandtheabilitytobettermeasuresomeoftheintermediate
steps. Progressinmodeldevelopmentmustbemadeinstepwith
increasingavailabilityofdata. Thisprogresswasillustratedinthe
paperspresentedby Chen(1), Hattis(2), andWilson (3) atthis
symposium.
Second, closely relatedtothetrendtowardincluding amore
completebiologicalpictureisatrendfromempiricalmodelsthat
basicaly involvecurvefiningtomorebiologicallybasedmodels.
Theexpandinginterestinphysiologicallybasedphanmcokinetic
models(4) andinmorebiologically descriptivecancermodels
developedbyMoolgavkarandcolleaguesthatexplicitdy incor-
porate the kinetics oftissue growth and development (5-7) il-
lustratethistrend. Hattis'presentationshowedapplicationsofthe
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former, whileWilson'spaper(3)hasprovidedadetailedhistory
ofthechanges inhigh-dosetolow-doseextrapolationmodeling
fromthemultistagemodelsofthe 1950s(8)tothemoregeneral
Moolgavkarmodel.
Chen's presentation (1) illustrated the increasing ability to
modelthebiologyofcarcinogenicprocessesinacasethatshows
the dependency of modeling on new biomedical research
measurements. Thiscasemayalsoindicatethereverseflow, that
understanding derived frommodels can lead to revisionofex-
perimental designs. Models ofthis kind may eventually allow
riskassessmentandregulatorystadardstotreatcarcinogensthat
have different mechanisms ofaction more appropriately, thus
leadingtomorerealisticriskassessments.
Although it may not seem so at first, a trend toward more
detailedbiologically basedmodels is notinconsistent with the
simpler "modelfree" approachproposedbyKrewski'spaper(9)
atthissymposium. Ifsufficientdataare notavailable to model
adequatelythefullprocess, itmaybebettertouseanextremely
simpleapproachtomakepreliminary estimates, ratherthanto
apply asophisticated model to arudimentary data set.
Third, there is a movement from reliance on upper-bound
estimates tobestestimates, with a morecomplete treatmentof
uncertainty andappropriatepropagationofuncertaintythrough
the different stages of analysis. Reliance on upper-bound
estimatesalonecandistortperceptionsofrisk,leadingunknow-
inglytoexcessivelyconservativeactions. Aspectsofuncertain-
tywerediscussedinseveralpapersatthissymposium. Mazum-
dar (JO), in particular, presented investigations ofjoint con-
fidenceregioncalculations andofrobustness inthemultistage
model that illustrate this increasing focus on understanding
uncertainty intheestimates.
Fourth,dtere isincreasingconsiderationofvariationincancer
susceptibility withintheexposedpopulation. Louis(11), Perera
(12), and Rockette (13) discussed this topic. Krewski (9)
examined the often raised concept that heterogeneity in the
population leads to a superlinear dose-response curve for the
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combined population. He concluded that this result was
possible only under highly improbable mixes of subgroup
susceptibility.
Fifth, one emerging area was not covered by any of the
speakers. Thatisthegrowingdevelopmentofexpert systemsand
decision support systems for use in risk assessment. Some
applications inthis areahaverecentlybeendescribed(14). The
topic wasthesubjectofseveralpapersatthe 1988annualmeeting
ofthe Society for Risk Analysis and has receivedconsiderable
attention fromtheEnvironmental ProtectionAgency'sOfficeof
Solid Waste and Emergency Response (15).
Sixth, the emerging field of risk communication was
mentioned briefly inthe session on Applications to Hazardous
Waste Sites. After overtwodecades ofquantitativeriskassess-
mentforradiationandchemicalcarcinogens, wehavediscovered
that the public does not care ifthe risk is 10-3 or 10-23. These
numbers do not have any meaning for them, and I sometimes
wonder how much real meaning they have for even the profes-
sionals inthefield. Despite alackofconcern withthespecifics
ofquantification, however, people are concerned about health
risks more than ever. I am convinced that feedback from risk
communication will change what we address in risk analysis,
how the analysis is done, and how the results are presented.
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